Skip to main content
Myron Cohen, MD, Infectious Disease, Chapel Hill, NC

MyronSCohenMD

Infectious Disease Chapel Hill, NC

Professor of Medicine, University of North Carolina School of Medicine

Dr. Cohen is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Cohen's full profile

Already have an account?

  • Office

    101 Manning Dr
    Chapel Hill, NC 27514
    Phone+1 919-966-4996
    Fax+1 919-843-5515

Education & Training

  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterFellowship, Infectious Disease, 1977 - 1979
  • University of Michigan
    University of MichiganResidency, Internal Medicine, 1974 - 1977
  • Rush Medical College of Rush University Medical Center
    Rush Medical College of Rush University Medical CenterClass of 1974
  • University of Illinois
    University of IllinoisB.S., Summa Cum Laude, 1969 - 1971

Certifications & Licensure

  • NC State Medical License
    NC State Medical License 1980 - 2025
  • MI State Medical License
    MI State Medical License Active through 1979
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Infectious Disease

Awards, Honors, & Recognition

  • National Academy of Medicine 2012
  • Association of American Physicians 2007
  • Faculty Service Award UNC General Alumni Association, 2015
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Covid-19, Ebola, and HIV — Leveraging Lessons to Maximize Impact  
    Connie Celum, Myron S Cohen, Wafaa El-Sadr, The New England Journal of Medicine
  • Monoclonal Antibodies for Prevention and Treatment of COVID-19  
    John R Mascola, Myron S Cohen, JAMA
  • Hydroxychloroquine for the Prevention of Covid-19 — Searching for Evidence  
    Myron Cohen, MD, The New England Journal of Medicine
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Lectures

  • HIV Vaccines (X2) 
    Keystone Symposia, Keystone, Colorado - 2/10/2013
  • B Cell Development and Function (X1) 
    Keystone Symposia, Keystone, Colorado - 2/10/2013
  • HIV Management 2012: The New York Course 
    The New York Course : HIV Management, New York, New York - 5/10/2012

Other

  • PEPFAR, Launched as an Emergency Response to AIDS, Has Built a Bridge to the Future 
    Myron Cohen, MD, STAT
    https://www.doximity.com/articles/04aeec55-0bc9-42e4-b378-30c377f7ecc1
    UpToDate, Wolters Kluwer Health - 2012-11-26
  • Syndromic treatment of gonococcal and chlamydial infection in women seeking primary care for genital discharge syndrome: decision-making. 
    Behets F, Miller WC, Cohen MS, Bulletin of the World Health Organization
    1/1/2001
  • Approaches to control sexually transmitted diseases Haiti from 1992 through 1995. 
    Behets F, Genece E, Narcisse M, Dallabetta G, Cohen MS, WHO Bulletin
    1/1/1998
  • Join now to see all

Authored Content

  • Monoclonal Antibodies for Prevention and Treatment of COVID-19June 2020
  • Hydroxychloroquine for the Prevention of Covid-19 — Searching for EvidenceJune 2020
  • Hydroxychloroquine for the Prevention of Covid-19 — Searching for EvidenceJune 2020
  • PEPFAR, Launched as an Emergency Response to AIDS, Has Built a Bridge to the FutureNovember 2018
  • Join now to see all

Press Mentions

  • A Valuable COVID Drug Won’t Work Against New Variant
    A Valuable COVID Drug Won’t Work Against New VariantJanuary 4th, 2023
  • A Valuable COVID Drug Doesn&Rsquo;T Work Against New Variants
    A Valuable COVID Drug Doesn&Rsquo;T Work Against New VariantsJanuary 3rd, 2023
  • Bug Bites and Infectious Diseases: What to Know
    Bug Bites and Infectious Diseases: What to KnowNovember 2nd, 2022
  • Join now to see all

Grant Support

  • HIV In Semen-Effects Of STDS And Antiviral TherapyNational Institute Of Diabetes And Digestive And Kidney Diseases2005–2012
  • Acute HIV-1 Infections Network CoreNational Institute Of Allergy And Infectious Diseases2006–2009
  • Acute HIV And STDS In MalawiNational Institute Of Allergy And Infectious Diseases2004–2008
  • Infectious Disease Pathogenesis Research TrainingNational Institute Of Allergy And Infectious Diseases1998–2007
  • Acute HIV-1 Infections Network CoreNational Institute Of Allergy And Infectious Diseases2005
  • HIV-1 In Plasma And Semen Of Men On HaartNational Center For Research Resources2004–2005
  • Effects Of Antiretroviral Therapy On The Excretion Of HIV In SemenNational Center For Research Resources2004
  • HIV In Semen--Effects Of STDS And Antiviral TherapyNational Institute Of Diabetes And Digestive And Kidney Diseases2000–2004
  • Core--Microbiology FacilityNational Institute Of Allergy And Infectious Diseases1999–2002
  • Core--Human Challenge FacilityNational Institute Of Allergy And Infectious Diseases1999–2002
  • Human Challenge Study Of Isogenic Mutants Of Neisseria GonorrhoeaeNational Center For Research Resources1996–2002
  • Study Of Isogenic Mutants Of Neisseria GonorrhoeaeNational Center For Research Resources2000
  • Intrasubject Variability Of Excretion Of HIV In Semen Over TimeNational Center For Research Resources2000
  • Sexually Transmitted Diseases Clinical Trials UnitNational Institute Of Allergy And Infectious Diseases1997–2000
  • HIV In Semen--Effects Of STDSNational Institute Of Diabetes And Digestive And Kidney Diseases1996–1999
  • Reaching HIV Through Gonorrhea--Network ApproachFogarty International Center1998
  • Core--Clinical/MicrobiologyNational Institute Of Allergy And Infectious Diseases1995–1998
  • A Challenge Study Of Neisseria GonorrhoeaeNational Institute Of Allergy And Infectious Diseases1995–1998
  • Inoculation Of Mutants Into UrethraNational Institute Of Allergy And Infectious Diseases1994
  • Core--MicrobiologyNational Institute Of Allergy And Infectious Diseases1994
  • Phagocytes, Free Radicals And Cellular ConsequencesNational Institute Of Allergy And Infectious Diseases1989–1991